Title : MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients.

Pub. Date : 2017 Mar

PMID : 28293479






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Multiple sclerosis (MS) patients treated with interferon beta (IFNbeta) are at risk of a declining response to treatment because of the production of IFNbeta-neutralizing antibodies (NAbs). nabs interferon beta 1 Homo sapiens
2 BACKGROUND: Multiple sclerosis (MS) patients treated with interferon beta (IFNbeta) are at risk of a declining response to treatment because of the production of IFNbeta-neutralizing antibodies (NAbs). nabs interferon beta 1 Homo sapiens
3 BACKGROUND: Multiple sclerosis (MS) patients treated with interferon beta (IFNbeta) are at risk of a declining response to treatment because of the production of IFNbeta-neutralizing antibodies (NAbs). nabs interferon beta 1 Homo sapiens